Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pramel Activators

Cytoplasmic proteins, such as the putative Pramel, exist within a dynamic environment of signaling cascades, each modulated by specific chemical entities. The activators listed above primarily influence general cellular processes or cytoplasmic pathways. For instance, elevators of cytosolic calcium, such as Thapsigargin and A23187, can trigger downstream events mediated by calcium-sensitive proteins. This elevation can initiate a cascade of events that may influence the activity, localization, or stability of proteins in the vicinity, including Pramel.

Similarly, various kinase pathways, pivotal in regulating cytoplasmic protein functions, can be influenced by activators such as PMA, Staurosporine, or cAMP analogs. The intricate web of kinase and phosphatase activity within the cytoplasm determines the phosphorylation status of countless proteins. By manipulating these pathways, one can alter the landscape of phosphorylated targets, modifying their function, including proteins like Pramel. Such activators, while not directly tied to Pramel, represent a toolbox for modulating the broader cellular environment. Careful selection and application of these chemicals can thus influence cytoplasmic protein activity, offering avenues to study or modulate the behavior of proteins in this cellular domain.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Protein synthesis inhibitor that activates the JNK pathway. The JNK pathway modulates a variety of cytoplasmic proteins, potentially influencing the function or localization of Pramel.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Serine/threonine protein phosphatase inhibitor. By inhibiting phosphatases, it can elevate phosphorylation events in the cytoplasm, potentially affecting Pramel.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibitor of protein phosphatases 1 and 2A, enhancing phosphorylation of various cytoplasmic proteins, possibly modulating Pramel indirectly.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PKC activator. Protein kinase C plays a role in multiple cytoplasmic signaling cascades, potentially influencing the activity or localization of Pramel.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Endoplasmic reticulum calcium ATPase inhibitor. It elevates cytosolic calcium, which can activate various calcium-dependent cytoplasmic pathways, possibly affecting Pramel.

Oligomycin

1404-19-9sc-203342
sc-203342C
10 mg
1 g
$149.00
$12495.00
18
(2)

ATP synthase inhibitor. Disruption of ATP levels can influence many cytoplasmic proteins and pathways, potentially having an effect on Pramel.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts protein transport from the ER to the Golgi apparatus, influencing various cytoplasmic proteins, potentially including Pramel.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Protein kinase inhibitor but has broad specificity, influencing various kinases in the cytoplasm which might indirectly affect Pramel.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Phosphodiesterase inhibitor, raising cAMP levels and activating PKA, a key kinase in many cytoplasmic pathways, potentially impacting Pramel.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

Analog of cAMP, activating PKA. By modulating PKA-dependent pathways in the cytoplasm, it might influence the function or localization of Pramel.